Idifarma provides contract development and manufacturing services for niche and highly potent generic or innovative drugs

Pharmaceutical R&D and Manufacturing Services

Idifarma is an independent, privately-owned pharmaceutical CDMO based in Spain and specializing in highly potent drugs.

With an experienced staff of 130+ people and over 100 international clients, Idifarma provides a full range of services covering most of the lifecycle of any pharmaceutical product from first pre-formulation trials to commercial manufacturing: drug formulation, development and validation of analytical methods, quality control and batch release in the EU, stability studies, regulatory affairs, GMP contract manufacturing and packaging for clinical or commercial use.

Its state-of-the-art facility features a purpose-built high containment plant for GMP manufacturing of oral solid dosage forms, for both highly potent and non-potent drugs.

Idifarma’s expertise, capabilities and proven track record make it the perfect partner for the development of your projects.



Welcome to the New @Idifarma
Flexible CDMO for Potent Drugs

Los próximos 16 y 17 de octubre, tendrán lugar los #5osEncuentrosEmpresariales en @baluarte
con presencia de empresas del sector #BioSalud de las regiones de #Aquitania #Navarra y #PaisVasco.
#Salud #Santé #Osasun #S3Navarra #SectoresEstratégicos

Our colleague, Lucía Erroba, from Business Development, will be attending "Encuentro Industria Bio-Salud" during this week (16-17th October, #Pamplona).

If you want to arrange a meeting, contact us at

We share our successes, from Nucaps we want to thank our partners for making all this possible: @CNTA_CIT @unav @Idifarma Clave @enisa @InnFactoryUnav @ceinnavarra @gob_na @EIT_Food @MassChallenge @Food4LifeSPAIN @YOU_MEDIA @InspiriaConsult @juanmirache @south_summit @asebio

Load More...

Do you want to receive the latest news from Idifarma?

Utilizamos cookies propias y de terceros para realizar el análisis de la navegación de los usuarios y mejorar nuestros servicios. Si continúa navegando, consideramos que acepta su uso. Puede obtener más información, o bien conocer cómo cambiar la configuración pulse aquí ACEPTAR

Aviso de cookies